Table 1 Demographic and clinical characteristics of the TRS Group and Non-TRS Group
Variables | TRS Group n = 79 | Non-TRS Group n = 182 | Statistic Values |
|---|---|---|---|
General information | |||
Age (years) | 41.8 [11.1] | 43.9 [11.5] | t = 1.375, P = 0.170 |
Sex: Male/Female (n) | 47/32 | 98/84 | Chi = 0.712, P = 0.400 |
Follow-up duration (days) | 6139.7 [3692.6] | 4477.8 [2269.7] | t = −3.708, P < 0.001 |
Duration before meeting TRS (days) | 3195.2 [3148.8] | – | |
Clinical index prior to treatment introduction | |||
Age at onset (years) | 24.0 [8.30] | 29.4 [9.63] | t = 4.306, P < 0.001 |
Premorbid social adjustment | 4.71 [3.15] | 3.61 [2.88] | t = −2.723, P = 0.007 |
DUP (months) | 9.61 [16.5] | 21.9 [47.8] | t = 1.976, |
DUP median | 3.00 | 3.75 | P = 0.049 |
Mode of onset: Acute/Insidious (n) | 38/41 | 74/108 | Chi = 1.245, P = 0.264 |
Clinical index related to FEP | |||
Duration of initial hospital admission (days) | 87.9 [205.6] | 53.3 [49.4] | t = −1.476, P = 0.144 |
GAF after FEP | 50.1 [16.6] | 61.0 [13.0] | t = 5.176, P < 0.001 |
GAF > 70 (n) | 11 | 52 | Chi = 6.454, P = 0.011 |
CP-dose for FEP treatment (mg) | 562.4 [410.5] | 703.4 [437.6] | t = 2.405, P = 0.017 |